A Trial of Intranasal Remimazolam Pharmacokinetics, Pharmacodynamics, Safety and Bioavailability

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2017
A prospective dose escalation, nine period cross-over trial assessing the safety, pharmacokinetics, bioavailability and pharmacodynamics of escalating doses of Remimazolam when administered intranasally as powder and solution in healthy subjects and compared to an intravenous control
Epistemonikos ID: 8a6cce34ccea52220113440c9cfeea3369cdd111
First added on: May 21, 2024